Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium
- PMID: 1332779
- DOI: 10.1016/0167-4889(92)90144-z
Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium
Abstract
The biochemical responses of intact human platelets to the monoclonal antibody (mAb) AG-1 were investigated. AG-1 is a murine IgG mAb that recognizes a series of platelet membrane glycoproteins (Gp) from M(r) 21,000 to 29,000, one of which is the M(r) 24,000 (p24) receptor for anti-CD9 mAbs. AG-1 causes platelet aggregation and secretion. Platelets binding AG-1 demonstrate a dose- and time-dependent breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2), production of diacylglycerol, and generation of phosphatidic acid (PA). These events are associated with the activation of protein kinase C (PKC), an increase in intracellular calcium, and fibrinogen binding. Platelet PA generation and PKC activation in response to AG-1 are inhibited by mAbs to platelet GpIIb-IIIa or by extracellular EGTA, but not by a mAb to platelet GpIb or by inhibiting platelet Na+/H+ exchange with 5-(N-ethyl-N-isopropyl)amiloride. Platelet cytoplasmic free calcium ([Ca2+]i) is elevated in response to AG-1, and this elevation is inhibited by mAbs to GpIIb-IIIa, an RGDS peptide or by chelating extracellular calcium. These results suggest that AG-1 binding to a unique platelet-surface glycoprotein initiates platelet responses through the activation of PIP2-specific phospholipase C, and that this occurs through a signal pathway that is dependent on GpIIb-IIIa and extracellular calcium.
Similar articles
-
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.J Clin Invest. 1991 Nov;88(5):1568-73. doi: 10.1172/JCI115468. J Clin Invest. 1991. PMID: 1939645 Free PMC article.
-
Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.Blood. 1994 May 1;83(9):2549-59. Blood. 1994. PMID: 8167340
-
Differences between platelet and microparticle glycoprotein IIb/IIIa.Cytometry. 1992;13(6):621-9. doi: 10.1002/cyto.990130610. Cytometry. 1992. PMID: 1451594
-
Platelet activation.Arteriosclerosis. 1985 Jan-Feb;5(1):2-18. doi: 10.1161/01.atv.5.1.2. Arteriosclerosis. 1985. PMID: 2981527 Review.
-
Use of monoclonal antibodies for the detection and analysis of activated human platelets.Curr Stud Hematol Blood Transfus. 1991;(58):26-31. doi: 10.1159/000419332. Curr Stud Hematol Blood Transfus. 1991. PMID: 1954770 Review. No abstract available.
Cited by
-
Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells.Pflugers Arch. 2007 Nov;455(2):283-96. doi: 10.1007/s00424-007-0285-4. Epub 2007 Aug 1. Pflugers Arch. 2007. PMID: 17668233
-
CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia.Hematol Transfus Cell Ther. 2019 Jul-Sep;41(3):205-211. doi: 10.1016/j.htct.2018.11.007. Epub 2019 Mar 30. Hematol Transfus Cell Ther. 2019. PMID: 31085145 Free PMC article.
-
An antibody to the tetraspan membrane protein CD9 promotes neurite formation in a partially alpha3beta1 integrin-dependent manner.J Neurosci. 1997 Apr 15;17(8):2756-65. doi: 10.1523/JNEUROSCI.17-08-02756.1997. J Neurosci. 1997. PMID: 9092597 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous